Medicinal composition fat emulsion injection containing eucalyptol, limonene and alpha-pinene and preparation method

A technology of limonene and eucalyptol, applied in the direction of drug combination, medical preparations containing active ingredients, medical preparations without active ingredients, etc., can solve the problems of inconvenient swallowing and unsatisfaction, and achieve the purpose of reducing bronchial mucosal swelling, Rapid onset of effects with clear active ingredients
CN101590033AActive Publication Date: 2009-12-02BEIJING GRAND JOHAUM PHARMA CO LTD

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
BEIJING GRAND JOHAUM PHARMA CO LTD
Publication Date
2009-12-02
Patent Text Reader

Abstract

The invention aims to develop medicinal composition fat emulsion injection containing eucalyptol, limonene and alpha-pinene and a preparation method. The preparation comprises the following components in percentage by weight: 0.0128 to 0.0320 percent of eucalyptol, 0.0084 to 0.0210 percent of limonene, 0.0028 to 0.0070 percent of alpha-pinene, 10 to 30 percent of soybean oil for injection, 1.0 to 1.5 percent of yolk lecithin for injection or 0.8 to 1.5 percent of soybean phospholipids for injection, 2.0 to 2.5 percent of glycerol for injection, and water for injection added to 100 milliliters. The preparation method has the characteristics of strong controllability of production quality, and definite treatment effect of a product. The invention fills up the blank of the medicinal composition fat emulsion injection preparation containing the eucalyptol, the limonene and the alpha-pinene.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of pharmaceutical preparations. Specifically relates to a fat emulsion injection containing eucalyptol, limonene and α-pinene pharmaceutical composition and a preparation method. Background technique

[0002] Phlegm is the product of respiratory inflammation, which can irritate the respiratory mucosa, cause cough and asthma, and aggravate infection. When patients with acute and chronic bronchitis or chronic lung disease have respiratory failure, if the patient's sputum is too viscous or forms sputum plugs, it can block the airway and cause suffocation. Therefore, it is of great significance to use mucus sputum regulators to dissolve mucus sputum, make it thinner, lower its viscosity, accelerate the movement of mucous membranes and cilia in the respiratory tract, and improve the transport function.

[0003] The currently marketed mucus regulators, such as bromhexine, sodium thioethanesulfonate, and carbocys...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More